C07K 2/00
Peptides of undefined number of amino acids
Official title: Peptides of undefined number of amino acids; Derivatives thereof
C07K2/00 (Peptides of undefined number of amino acids) appears on 247 US grants and 387 published applications in this corpus.
Search patents in C07K- Granted patents
- 247
- Published applications
- 387
- Assignees
- 222
- Inventors
- 718
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 4 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 2 |
| 2002 | 4 | 4 |
| 2003 | 1 | 7 |
| 2004 | 0 | 6 |
| 2005 | 2 | 2 |
| 2006 | 6 | 7 |
| 2007 | 1 | 5 |
| 2008 | 2 | 12 |
| 2009 | 2 | 5 |
| 2010 | 8 | 9 |
| 2011 | 6 | 11 |
| 2012 | 9 | 18 |
| 2013 | 10 | 50 |
| 2014 | 21 | 31 |
| 2015 | 22 | 33 |
| 2016 | 18 | 24 |
| 2017 | 20 | 20 |
| 2018 | 15 | 31 |
| 2019 | 18 | 26 |
| 2020 | 10 | 21 |
| 2021 | 11 | 16 |
| 2022 | 14 | 18 |
| 2023 | 15 | 10 |
| 2024 | 8 | 12 |
| 2025 | 8 | 2 |
| 2026 | 4 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Process for obtaining protein-rich nutrient supplements from bacterial fermentation process30 Jun 2026US 12,668,827 B2
- Proteins for the treatment of epithelial barrier function disorders23 Jun 2026US 12,661,383 B2Genevive, Inc.
- Orthogonal Cas9 proteins for RNA-guided gene regulation and editing17 Mar 2026US 12,577,590 B2President and Fellows of Harvard College
- Peptide for treating inflammation and wounds10 Feb 2026US 12,545,704 B2Nibec Co., Ltd.
- Methods, plants and compositions for overcoming nutrient suppression of mycorrhizal symbiosis23 Dec 2025US 12,503,707 B2Cambridge Enterprise Limited
- Proteins for the treatment of epithelial barrier function disorders24 Sep 2026US 2026/0284140 A1Genevive, Inc.
- Orthogonal Cas9 Proteins for RNA-Guided Gene Regulation and Editing11 Jun 2026US 2026/0159856 A1President and Fellows of Harvard College
- Targeted drug conjugate, medicine including same, and compound28 May 2026US 2026/0144886 A1FUJIFILM Corporation
- Novel phage libraries of bicyclic peptides14 May 2026US 2026/0132547 A1The Trustees of Boston College
- Methods, plants and compositions for overcoming nutrient suppression of mycorrhizal symbiosis26 Feb 2026US 2026/0055423 A1Cambridge Enterprise Limited
Most cited
By later US patents
- Molecules with extended half-lives, compositions and uses thereof342US 7,083,784 B2MedImmune, LLC · 2006
- DLIN-KC2-DMA lipid nanoparticle delivery of modified polynucleotides189US 8,754,062 B2Moderna Therapeutics, Inc. · 2014
- Modified polynucleotides for the production of G-CSF164US 8,680,069 B2Moderna Therapeutics, Inc. · 2014
- Molecules with extended half-lives, compositions and uses thereof159US 7,670,600 B2Board of Regents, The University of Texas System · 2010
- Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports123US 7,211,654 B2The Regents of the University of Michigan · 2007